2/16
06:40 am
tech
Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge-Based Immunoassays for European Clinical Laboratories [Yahoo! Finance]
Low
Report
Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge-Based Immunoassays for European Clinical Laboratories [Yahoo! Finance]
2/16
06:30 am
tech
Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge-Based Immunoassays for European Clinical Laboratories
Low
Report
Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge-Based Immunoassays for European Clinical Laboratories
2/11
09:00 am
tech
Bio-Techne Announces Changes to its Leadership Team
Low
Report
Bio-Techne Announces Changes to its Leadership Team
2/11
07:24 am
tech
Bio-Techne (NASDAQ:TECH) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Medium
Report
Bio-Techne (NASDAQ:TECH) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
2/6
11:16 am
tech
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at Wells Fargo & Company from $70.00 to $76.00. They now have an "overweight" rating on the stock.
Low
Report
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at Wells Fargo & Company from $70.00 to $76.00. They now have an "overweight" rating on the stock.
2/5
10:58 am
tech
Bio-Techne (NASDAQ:TECH) was given a new $65.00 price target on by analysts at Stifel Nicolaus.
Low
Report
Bio-Techne (NASDAQ:TECH) was given a new $65.00 price target on by analysts at Stifel Nicolaus.
2/5
10:27 am
tech
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at Evercore ISI from $62.00 to $68.00. They now have an "in-line" rating on the stock.
Low
Report
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at Evercore ISI from $62.00 to $68.00. They now have an "in-line" rating on the stock.
2/5
10:04 am
tech
Bio-Techne (NASDAQ:TECH) was given a new $70.00 price target on by analysts at Robert W. Baird.
Low
Report
Bio-Techne (NASDAQ:TECH) was given a new $70.00 price target on by analysts at Robert W. Baird.
2/5
08:11 am
tech
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at TD Cowen.
Low
Report
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at TD Cowen.
2/5
08:11 am
tech
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at UBS Group AG.
2/4
07:13 pm
tech
Bio-Techne Corp (TECH) Q2 2026 Earnings Call Highlights: Strategic Growth and Margin Expansion ... [Yahoo! Finance]
Medium
Report
Bio-Techne Corp (TECH) Q2 2026 Earnings Call Highlights: Strategic Growth and Margin Expansion ... [Yahoo! Finance]
2/4
02:04 pm
tech
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
2/4
01:31 pm
tech
Bio-Techne Corporation (TECH) Q2 2026 Earnings Call Transcript [Seeking Alpha]
Low
Report
Bio-Techne Corporation (TECH) Q2 2026 Earnings Call Transcript [Seeking Alpha]
2/4
10:55 am
tech
Bio-Techne (TECH) Q2 2026 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Bio-Techne (TECH) Q2 2026 Earnings Call Transcript [Yahoo! Finance]
2/4
10:25 am
tech
Bio-Techne (NASDAQ:TECH) Surprises With Q4 CY2025 Sales [Yahoo! Finance]
Low
Report
Bio-Techne (NASDAQ:TECH) Surprises With Q4 CY2025 Sales [Yahoo! Finance]
2/4
08:40 am
tech
Biotech firm Bio-Techne beats quarterly estimates on strength in key unit [Yahoo! Finance]
Low
Report
Biotech firm Bio-Techne beats quarterly estimates on strength in key unit [Yahoo! Finance]
2/4
07:22 am
tech
Bio-Techne Releases Second Quarter Fiscal 2026 Results [Yahoo! Finance]
Medium
Report
Bio-Techne Releases Second Quarter Fiscal 2026 Results [Yahoo! Finance]
2/4
06:30 am
tech
Bio-Techne Releases Second Quarter Fiscal 2026 Results
Medium
Report
Bio-Techne Releases Second Quarter Fiscal 2026 Results
2/4
06:30 am
tech
Bio-Techne Declares Dividend
Medium
Report
Bio-Techne Declares Dividend
2/3
12:01 pm
tech
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at Benchmark Co..
Low
Report
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at Benchmark Co..
2/3
09:49 am
tech
Is Bio-Techne (TECH) Fairly Priced After Recent Share Price Rebound? [Yahoo! Finance]
Low
Report
Is Bio-Techne (TECH) Fairly Priced After Recent Share Price Rebound? [Yahoo! Finance]
2/2
10:11 pm
tech
Bio-Techne (TECH) Reports Earnings Tomorrow: What To Expect [Yahoo! Finance]
Low
Report
Bio-Techne (TECH) Reports Earnings Tomorrow: What To Expect [Yahoo! Finance]
2/2
06:40 am
tech
Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative [Yahoo! Finance]
Low
Report
Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative [Yahoo! Finance]
2/2
06:30 am
tech
Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative
Low
Report
Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative
1/28
06:46 am
tech
Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers [Yahoo! Finance]
Medium
Report
Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers [Yahoo! Finance]